Kestra Medical Technologies, LTD. (KMTS) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2026, Kestra Medical Technologies reported revenue of $95.1M, up 59.0% from $59.8M the year before. Net income was -$131.6M (a -138.4% net margin), or -$2.43 per diluted share. Gross margin was 51.4% and operating margin was -141.6%. Operating activities generated -$81.7M of cash, leaving -$116.6M of free cash flow. At fiscal year end, Kestra Medical Technologies held $358.5M in total assets against $98.8M in total liabilities, including $99.7M of cash and equivalents.
Open the full interactive Kestra Medical Technologies financials → Quarterly statements, key ratios, valuation history and price charts.
Kestra Medical Technologies Key Stats
| Share Price | $26.97 |
|---|---|
| Market Cap | $1.58B |
| Revenue YoY Growth | +59.0% |
| 52-Week Range | $17.87 – $28.46 |
| Shares Outstanding | 58.6 million (basic, 2027 Q1) |
Kestra Medical Technologies Income Statement
| FY 2025 | FY 2026 | |
|---|---|---|
| Revenue | $59.8M | $95.1M |
| Cost of Goods Sold | $35.6M | $46.3M |
| Gross Profit | $24.2M | $48.9M |
| Operating Income | -$106.4M | -$134.7M |
| Pre-Tax Income | -$113.7M | -$131.3M |
| Income Tax | $135,000 | $294,000 |
| Net Income | -$113.8M | -$131.6M |
| Diluted EPS | -$5.13 | -$2.43 |
Kestra Medical Technologies Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $22.6M | $24.6M | $28.6M | $31.0M |
| Net Income | -$32.8M | -$34.2M | -$38.8M | -$44.1M |
| Diluted EPS | -$0.64 | -$0.61 | -$0.72 | -$0.75 |
Kestra Medical Technologies Balance Sheet
| FY 2025 | FY 2026 | |
|---|---|---|
| Cash & Equivalents | $237.6M | $99.7M |
| Current Assets | $255.3M | $222.4M |
| Total Assets | $295.7M | $358.5M |
| Current Liabilities | $38.0M | $50.4M |
| Total Long-Term Debt | $41.1M | $42.6M |
| Total Liabilities | $90.3M | $98.8M |
| Shareholders' Equity | $205.4M | $259.7M |
Kestra Medical Technologies Cash Flow Statement
| FY 2025 | FY 2026 | |
|---|---|---|
| Cash From Operations | -$77.6M | -$81.7M |
| Cash From Investing | -$23.3M | -$203.3M |
| Cash From Financing | $330.3M | $147.1M |
| Free Cash Flow | -$100.5M | -$116.6M |
Figures from Kestra Medical Technologies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Kestra Medical Technologies financials page for every line item.
Kestra Medical Technologies Company Profile
| Ticker | KMTS |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Kirkland, Washington |
| Fiscal Year End | April 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001877184 |
Frequently Asked Questions
What was Kestra Medical Technologies' revenue in fiscal 2026?
Kestra Medical Technologies (KMTS) reported revenue of $95.1M for fiscal 2026.
What was Kestra Medical Technologies' net income in fiscal 2026?
Kestra Medical Technologies reported net income of -$131.6M for fiscal 2026.
What was Kestra Medical Technologies' earnings per share (EPS) in fiscal 2026?
Kestra Medical Technologies' diluted EPS was -$2.43 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Kestra Medical Technologies generate in fiscal 2026?
Kestra Medical Technologies generated -$116.6M of free cash flow in fiscal 2026.
What was Kestra Medical Technologies' revenue last quarter?
In its most recent reported quarter (2027 Q1), Kestra Medical Technologies reported revenue of $31.0M.
How much debt does Kestra Medical Technologies have?
Kestra Medical Technologies reported $42.6M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Kestra Medical Technologies are outstanding?
Kestra Medical Technologies reported a weighted average of 58.6 million basic shares outstanding in 2027 Q1.
What is Kestra Medical Technologies' market cap?
Based on its latest closing price, Kestra Medical Technologies (KMTS) has a market capitalization of about $1.58B.
When does Kestra Medical Technologies' fiscal year end?
Kestra Medical Technologies' fiscal year end, as registered with the SEC, is April 30.
Where is Kestra Medical Technologies headquartered?
Kestra Medical Technologies lists its business address in Kirkland, Washington in its SEC filings.
Kestra Medical Technologies Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →